Surance Plus

Gain Entry to an Investment Class
Previously Accessible Only to Ultra-High Net Worth Investors

The HCI Re Series is closed to new investment. Account holders can sign in here.

HCI Re 2026 Series A Series B Series C
Company / Issuer SurancePlus Inc. SurancePlus Inc. SurancePlus Inc.
Description Tokenized Reinsurance Security Tokenized Reinsurance Security Tokenized Reinsurance Security
Token Name HCI Re 2026 Series A HCI Re 2026 Series B HCI Re 2026 Series C
Number of tokens available 100,000 100,000 100,000
Specific Reinsurer Fortex Re Segregated Portfolio #2 Fortex Re Segregated Portfolio #3 Fortex Re Segregated Portfolio #4
Mirrored Contract ID U8GR0001-F / Tower 1 26\C0KT1013-F / Tower 3 26\C0KT1023-F / Tower 3
Layer Layer 1 (1st event) Underlying Layer RPP Layer 2
Specific Contract Layer $80m xs $10m $12.25m xs $2.75m (1PP) $16m xs $100m
Pricing $11.10 $22.12 $30.01
Target ROI* 224% 122% 17%
Estimated Redemption Value Per Token* $36.00 $49.00 $35.20
Expected Loss** 20.51% 32.36% 4.19%
Attachment Probability** 32.22% 35.45% 6.60%
Exhaustion Probability** 14.96% 23.35% 2.37%
Investor Eligibility U.S (Accredited) and Non-U.S. U.S (Accredited) and Non-U.S. U.S (Accredited) and Non-U.S.
Minimum Investment $5,000 for individuals, $50,000 for entities $5,000 for individuals, $50,000 for entities $5,000 for individuals, $50,000 for entities
Transfer Restrictions Subject to Reg D and Reg S requirements Subject to Reg D and Reg S requirements Subject to Reg D and Reg S requirements
Value Transfer USD USD USD
Tokenization Agent Vulcan Forge by Alphaledger Technologies, Inc Vulcan Forge by Alphaledger Technologies, Inc Vulcan Forge by Alphaledger Technologies, Inc
Network Exclusively on Solana Exclusively on Solana Exclusively on Solana
Annual Contract Term June 1, 2026 - May 31, 2027 June 1, 2026 - May 31, 2027 June 1, 2026 - May 31, 2027
Subscription Window Subscribe by June 25, 2026 Subscribe by June 25, 2026 Subscribe by June 25, 2026

* Assuming no underwriting losses and before any interest income.

** Modeled loss profile statistics based on RMS RiskLink v23.0 (Long-Term Hurricane and Severe Convection Storm), and incorporation a 15.0% Loss Adjustment Expense (LAE) factor; attachment and exhaustion probabilities reflect the first occurrence limit on risk; statistics are reflective of a 12-month term.

Unlock an exclusive investment opportunity traditionally reserved for ultra-high net worth individuals: Reinsurance.

Reserve your seat at the table by booking a call today.

2026 offering – open through June 25, 2026

$5,000

Minimum Investment

17% - 224%

Annualized Return

$11.01 - $30.01

Per Share

Embracing Global Innovation & Advanced Finance

RWA

Blockchain

Liquidity

Where Innovation Finds Investment.

This opportunity, once exclusive to only ultra-high-net-worth individuals, aligns with U.S. Securities laws, thanks to rigorous regulatory oversight. It leverages the extensive expertise of our parent company, Oxbridge Re, which has over a decade of experience in the reinsurance industry.

Asset-Backed Investment Security

The HCI Re Series Tokens will be offered and sold to U.S. and non-U.S. investors in compliance with exemptions from registration provided under United States securities laws.

Asset-Backed

The tokenized reinsurance securities are backed by RWAs (reinsurance contracts) that comply with applicable U.S. securities laws. Monies are held in U.S. Bank Trust accounts that are not exposed to fluctuations in the capital markets.

Attractive ROI

Holders of this year’s HCI Re 2026 Series' A, B & C Tokens are projected to receive a targeted return of 17%, 122% and/or or 224% annualized return, respectively.*

Transparency and Compliance

SurancePlus is a subsidiary of Oxbridge Re Holdings (NASDAQ: OXBR), a publicly traded company that is audited to Public Company Accounting Oversight Board (PCAOB) standards.

Invest in Real-World Assets with SurancePlus

Exclusive Investment Access

Gain access to an investment

opportunity traditionally only accessible to ultra-high net worth individuals.

Profitable Reinsurance Ventures

Earn an estimated 17%, 122% or 224% ROI when you invest with SurancePlus, a subsidiary of NASDAQ-listed Oxbridge Re, in reinsurance contracts (insurance for insurance companies). Examples of large reinsurers are Berkshire Hathaway and Lloyd’s of London.

Non-Correlated Opportunities

Through Oxbridge Re, SurancePlus offers a high-return alternative investment not correlated to stock-market fluctuations.

Proven Track Record

Investors in the 2025/26 EtaCat Re and ZetaCat Re offering are on track to receive a 29% or 44% annualized return as filed with the U.S. Securities and Exchange Commission (SEC).

What is Reinsurance?

Put simply, reinsurance is insurance for insurance companies. It is a $700 billion industry.

Insurance companies purchase reinsurance to reduce risks associated with the occurrence of exceptional, catastrophic events, such as hurricanes, that could expose them to significant losses and potentially put them out of business.

The Best Part? It’s Non-Market Correlated

Now more than ever, investors need financial products that are uncorrelated to the volatility of this current macro-economic backdrop. Reinsurance presents a great alternative investment opportunity that is decoupled from the fluctuations of the capital markets.

Why is it decoupled? Direct or derivative investments in reinsurance are impacted by exceptional catastrophic events like hurricanes. These are not directly correlated to the events originating on the stock market. With SurancePlus by Oxbridge Re, capital invested in reinsurance is deposited into U.S. bank trust accounts alongside insurers’ premiums and/or capital partners collateral to fully collateralize the reinsurance or reinsurance derivative contracts with no market exposure.

Sign Up on Our Investor Portal

Making an investment is simple. Visit our easy-to-use Investor Portal to download and read the offering documents. Then, complete your investment with as little as $5,000!

Book Your No Obligation Investment Call Today and Learn More:

Access to this opportunity ends on June 25, 2026.

Closed products

Balanced-Yield Strategy

High-Yield Strategy

Scroll to Top